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PermeabilizationThe intrinsically disordered protein a-synuclein (aSN) is linked to Parkinson’s Disease and forms
both oligomeric species and amyloid ﬁbrils. The N-terminal part of monomeric aSN interacts
strongly with membranes and aSN cytotoxicity has been attributed to oligomers’ ability to interact
with and perturb membranes. We show that membrane folding of monomeric wt aSN and N-termi-
nally truncated variants correlates with membrane permeabilization. Further, the ﬁrst 11 N-termi-
nal residues are crucial for monomers’ and oligomers’ interactions with and permeabilization of
membranes. We attribute oligomer permeabilization both to cooperative electrostatic interactions
through the N-terminus and interactions mediated by hydrophobic regions in the oligomer.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Though intrinsically disordered [1], the presynaptic protein a-
synuclein (aSN) can fold into membranes in vivo [2] and in vitro
[3,4]. Association of aSN with membranes has been linked to its
physiological role [5] and its part in the pathogenesis of Parkin-
son’s Disease (PD). aSN is the main component of PD-associated
intracellular deposits known as Lewy Bodies [6], and aSN muta-
tions lead to early onset PD [7]. aSN also forms aggregates both
in vitro and in vivo, including oligomers and amyloid ﬁbrils which
also interact with membranes [8–10].
The aSN primary sequence forms three regions (Fig. 1A). The
N-terminal region is important for membrane binding [11–13]
while the NAC (non-amyloid-b component) region nucleates
amyloid ﬁbril formation [14] and the C-terminal region is typicalfor an intrinsically disordered region [15]. In sodium dodecyl
sulfate (SDS) micelles, aSN forms two helices, helix-N (residues
3–37) and helix-C (residues 45–92) connected by an ordered
extended linker in an antiparallel arrangement. Another extended
region (residues 93–97) is followed by an unstructured C-terminus
(residues 98–140) [16]. Consistently, residues 1–100 interact with
membranes [3,17]. Binding may be a two-step process initiated by
residues 3–25 which anchor aSN to the membrane, after which
residues 25–100 undergo a coil? helix transition [18,19]. Deletion
of the ﬁrst N-terminal residues reduces toxicity towards yeast;
toxicity is completely reduced by deleting residues 2–11 [20].
Yeast toxicity correlates with the different deletion mutants’ mem-
brane binding [20], indicating a direct link between aSN toxicity
and membrane binding. The importance of residues 2–11 on mem-
brane interaction has been underlined in another study, where the
quantitative binding of aSN to isolated mitochondria was
abolished when residues 2–11 were deleted [21].
Although neurodegenerative diseases such as PD and Alzheimer’s
Disease were initially mainly associated with amyloid deposits,
there is growing consensus that non- or pre-ﬁbrillar oligomeric
species are the cytotoxic species [22–28]. This may be linked to
their structure and ability to interact with membranes. Though
inherent polydispersity and low oligomer yields have precluded
detailed molecular analysis of membrane interactions, single
050
100
150
200
250
300
350
400 450 500 550 600
A
N
S 
flu
or
es
ce
nc
e 
(a.
u.)
Wavelength (nm)
C
Monomers
Oligomers
0
5
10
15
20
450 480 510 540
A 1-60 N-terminal
Basic; pI 9.5
61-95 NAC 96-140 C-terminal
Acidic; pI 3.8
3-97 membrane bound
DVFMKGLSKA
Residues 2-11
Initiates coil-helix transition
when binding anionic membranes Nucleates amyloid formation
Typical of intrinsically 
disordered region
Mutants Del 2, Del 2-5 and  Del 2-11 lack residues 2, 2-5 and 2-11, respectively.
0
4
8
12
16
20
24
28
1 10 100
wt
del 2 
del 2-5
del 2-11
N
um
be
r 
(%
)
Radius (nm)
B
Fig. 1. Oligomer structure and hydrophobicity. (A) Schematic representation of aSN including deletions at the N-terminus. (B) Oligomer radii determined by DLS. (C) ANS
ﬂuorescence of monomers and oligomers. Legends as in B including ANS control (x). Insert: Zoom of monomer spectra.
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anionic lipids, preferentially in liquid disordered regions [12,29].
Hydrophobic interactions are likely important for oligomer–mem-
brane interactions, given that the binding is strongest when the bi-
layer is loosely packed, making the hydrophobic membrane
interior more accessible [29].
Here we report that N-terminal truncation mutants of aSN af-
fect folding into, binding and permeabilization of anionic large uni-
lamellar vesicles (LUVs). Monomer ability to permeabilize
membranes correlates with their degree of folding in membranes.
Monomeric and oligomeric membrane permeabilization can be
abolished by deleting residues 2–11 in the N-terminal, highlighting
the N-terminal’s critical role in both species’ membrane interac-
tion. We suggest that the pronounced ability of aSN oligomers to
permeabilize vesicles stems from a combination of N-terminal
electrostatic interactions and the formation of hydrophobic
patches in the oligomer structure.
2. Materials and methods
2.1. Materials
Lipids were from Avanti Polar Lipids (Alabaster, AL); unless
otherwise stated, all other chemicals were from Sigma Aldrich
(St. Louis, MO). PBS buffer (20 mM phosphate, 150 mM NaCl, pH
7.4) was used throughout. Plasmids containing N-terminal deletion
mutants (Fig. 1A) were a generous gift from P. Lansbury.
2.2. Protein handling
Mutants were expressed and puriﬁed as described in [30] and
Supplementary Information (SI). Immediately prior to allexperiments, lyophilized aSN was dissolved in PBS buffer and
ﬁltered (0.2 lm). Protein concentration was determined by
absorbance measurements with a NanoDrop™ 1000 spectropho-
tometer (Thermo Scientiﬁc) using a theoretical extinction coefﬁ-
cient of 5900 M1 cm1.
2.3. Vesicle preparation
Large unilamellar vesicles (LUVs) of pure 1,2-dimyristoyl-sn-3-
phosphatidylglycerol (DMPG) or 1,2-dioleoyl-sn-3-phosphatidyl-
glycerol (DOPG) were prepared by 10 freeze-thaw cycles followed
by 21 extrusions to the desired diameter [31].
2.4. Oligomer puriﬁcation
Oligomers were puriﬁed as described in [8,32]. Brieﬂy, mono-
meric aSN was dissolved to 840 lM and incubated at 900 rpm,
37 C at 5–6 h. Soluble oligomers were puriﬁed from insoluble
material by centrifugation at 13.400 rpm, RT, in 10 min. The super-
natant was loaded on a Superdex 200 (10/300G L) and oligomers
collected, baseline separated from monomers. Oligomers were
concentrated using a 2H2 U-Tube centrifugation concentrator with
a cutoff of 2 kDa (Novagen) and stored at 4 C. Oligomers were gen-
erally used readily after puriﬁcation.
2.5. Dynamic light scattering (DLS)
We used a ZS Zetasizer Nano ZS (Malvern Instruments) to mea-
sure oligomeric hydrodynamic radius (RH) at 25 C at 21–42 lM
oligomer. Oligomer samples were analyzed readily after puriﬁca-
tion with SEC. All samples were measured ﬁve times using 15–40
accumulated scans to give number-percentage averaged RH.
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10 lM of aSN monomer or oligomer was mixed with 10 lM
1-anilinonaphthalene-8-sulfonate (ANS) in PBS buffer. ANS ﬂuo-
rescence was measured on a LS55 luminescence spectrophotome-
ter (Perkin Elmer Instruments) using excitation at 365 and
400–600 nm emission, 10 nm slit widths and 150 nm/min scan
speed. Five spectra were averaged for each sample.
Note: Details of protein puriﬁcation, ﬁbrillation assays, asym-
metrical ﬂow ﬁeld-ﬂow fractionation (A4F), calcein release assay
and folding assay are provided in SI.
3. Results
3.1. Formation and analysis of amyloid ﬁbrils and oligomers
To evaluate the importance of the ﬁrst 11 N-terminal residues
of aSN in different membrane binding assays, we have studied
deletion mutants Del2, Del2-5 and Del2-11 (Fig. 1A). All mutants
formed amyloid ﬁbrils in vitro both in an SDS-induced and a shak-
ing-induced ﬁbrillation assay (Fig. S1). While Del2-11 showed sig-
niﬁcantly longer lag times than the other aSN constructs and
followed an erratic aggregation proﬁle, Del2 ﬁbrillated with the
shortest lag times in both assays (Fig. S1). All deletion mutants
formed oligomers of the same size as wildtype (wt), eluting close
to the exclusion limit (Mr = 1.3  106 Da) of the Superdex 200 size
exclusion chromatography (SEC) column. Therefore we used dy-
namic light scattering (DLS) and found that all mutants had com-
parable hydrodynamic radii (Rh) of 9.9–11.7 nm (Fig. 1B &
Table 1). The number distribution shows reasonable oligomer
monodispersity (Fig. 1B).
To identify hydrophobic patches on oligomers, we used the dye
ANS, whose ﬂuorescence increases and blue shifts upon binding to
hydrophobic regions [33]. ANS ﬂuorescence was not affected by
monomers, but oligomers induced both a blue shift and an inten-
sity increase (Fig. 1C). The monomer averaged emission ﬂuores-
cence maximum <kmaxmonomer> = 510 nm while <kmaxoligomer> =
474 nm, indicating formation of hydrophobic patches on the oligo-
mers. kmaxoligomer varies little (472.5–477.5 nm, Table 1), indicating
small variations in hydrophobicity.
3.2. Monomer–membrane interactions correlate with degree of folding
We have measured aSN membrane binding, folding in mem-
branes and membrane permeabilization, respectively. As a simple
measure of binding, we used asymmetrical ﬂow ﬁeld-ﬂow frac-
tionation (A4F) to quantitatively evaluate the association of mono-
mers and oligomers to DOPG vesicles. A4F has a uniquely broad
separation range and we have previously used this method to sep-
arate and analyze monomer and oligomeric populations during the
ﬁbril formation of the protein TGFIBp [34] and to show that no sig-
niﬁcant oligomeric species are formed during ﬁbril formation of
the protein S6 [35]. Furthermore, A4F is also capable of separating
LUVs [36], and we have designed a cross-ﬂow gradient (See SI)
which enables near baseline separation of monomers, oligomers
and DOPG vesicles (Fig. 2A and B, 3B, SI2). Degree of binding was
estimated by comparing peak area (214 nm absorbance) of mono-
mers incubated ± DOPG vesicles, at a mole ratio of 1:100 (pro-
tein:lipid) (Fig. 2A and B). For wt, Del2 and Del2–5, >70% of the
monomers were membrane-associated, whereas <10% of Del2–11
was membrane-associated (Fig. 2A and B, Table 1).
Monitored by circular dichroism (CD), binding and folding of wt
aSN monomers in vesicles is a coil? helix transition which re-
quires the lipids to be in the liquid disordered phase [31]. We ana-
lyze the folding (degree of helix formation) of the different deletionmutants in DMPG vesicles with a mole ratio of 1:21 (protein:lipid)
between 5 and 100 C. 215 nm was chosen as it lies between the
two minima of 222 and 209 nm observed for membrane bound
monomer [31]. Both the transition broadness and amplitude (min-
imum) as observed by the CD scans (Fig. 2C) revealed clear differ-
ences between the deletion mutants and wt. Del2–11 undergoes
very little folding, Del2–5 folds only slightly less than wt and
Del2 folds to an even greater extent than wt (Fig. 2C). The dye leak-
age experiment revealed the same trend: Del2 was more potent
than wt, Del2–5 less potent than wt and Del2–11 did not induce
any signiﬁcant release (Fig. 2D). To correlate the ability of the
monomers to permeabilize membranes with membrane folding,
we plot the protein concentration needed for 50% dye leakage with
the temperature range of folding (the temperature range where a
coil? helix transition is observed) (Fig. 2D insert). The reasonable
linearity predicts Del2–11 to have a 5.5 times higher concentration
for 50% dye leakage than wt (Table 1).
3.3. Oligomer–membrane interactions follow the same pattern as the
monomers, but the ranking in the permeabilization assay differ slightly
Wt, Del2 and Del2–5 oligomers led to similar membrane afﬁn-
ities as monomers according to A4F measurements, >70% associ-
ated with membranes (Fig. 3A, Table 1). We were unable to
analyze Del2–11 oligomers in the A4F experiment due to the low
oligomer yield obtained with this mutant (Table 1). However, in
dye leakage experiments, the wt oligomer was the most potent
and there was no signiﬁcant difference between Del2 and Del2–5
oligomers (Fig. 3B). Del2–11 induced up to 40% dye leakage, which
is better than the near-complete lack of effect of Del2–11 mono-
mers. At micromolar level, wt and Del2–5 oligomers were 31 and
23 times more potent in dye leakage, respectively, than the corre-
sponding monomer, while the Del2 oligomer is only 7 times more
potent than the Del2 monomer (Table 1).
4. Discussion
4.1. Formation of amyloid ﬁbrils and oligomers
Despite the slow and somewhat stochastic ﬁbrillation kinetics
of Del2–11, deletions within the ﬁrst 11N-terminal residues did
not remove the ability of aSN to form amyloid ﬁbrils, consistent
with reports that truncated variants of aSN (residues 30–110 and
11–140) forms amyloid ﬁbrils indistinguishable from wt [37]. All
mutants were able to form oligomers, wt, Del2 and Del2–5 at com-
parable levels whereas we obtained a signiﬁcant lower yield of
Del2–11 oligomers. The RH of the oligomers, as determined by
DLS, are comparable. Thus, deletions in the ﬁrst 11 residues of
the N-terminal affect neither oligomer nor ﬁbril gross structure.
4.2. Monomer: membrane permeabilization correlates with folding in
the membrane
The degree of membrane binding of Del2 and Del2–5 monomers
was similar to wt monomers, whereas Del2–11 has a severely low-
ered afﬁnity (Table 1). This correlates with monomer folding in
DMPG vesicles, where Del2–11 has a radical decrease in structure
formation relative to the others. This is reasonable, since less bind-
ing should lead to less folding. Deletion of Asp2 (Del2) decreases
electrostatic repulsion between aSN and the negative charges at
the membrane interface, possibly leading to a more energetically
favorable binding interaction which could explain the increase in
folding of the Del2 monomers relative to wt (Fig. 2C). Del2–5 re-
duces folding relative to Del2 and wt. Here the positive contribu-
tion of removing Asp2 to the folding is cancelled by the deletion
Table 1
Overview of determined parameters for wt aSN and deletion mutants.
Mutant CR50%
monomera
CR50%
oligomerb
CR50%
monomer:CR50%
oligomerc
Monomer membrane
folding range (C)d
Monomer
vesicle
interactione
Oligomer
vesicle
interactionf
RH of
oligomers
(nm)g
kmax,
ANS
(nm)h
Oligomer
yield i
l
(yeast)
(h1) j
Wt 2.8 0.09 31 54 + + 11.7 ± 3.2 473.5 1.5 0.04
Del2 1.8 0.26 7 61 + + 9.9 ± 2.5 474.0 1.5 0.14
Del2–5 6.4 0.26 23 46 + + 10.9 ± 2.6 477.5 1.2 0.19
Del2–
11
15.5k N/Al N/Al 16  N/Al 10.5 ± 2.6 472.5 0.2 0.22
Notes: a,b Protein concentration leading to 50% vesicle permeabilization (lM).
e,f Interaction of monomer/oligomer with DOPG vesicles. ‘‘’’: <10% and ‘‘+’’: >70% bound.
c Ratio of a and b.
d Temperature interval in which the monomer is folded in DMPG vesicles.
g Hydrodynamic radius, given as the number mean of oligomers, determined with DLS. In all cases, the peak integral of the oligomers is 100%.
h kmax of ANS ﬂuorescence of oligomers.
i Percentage oligomer eluting from the SEC column relative to total aSN. These vary signiﬁcantly between different puriﬁcations with standard deviations of 60–80%.
j Yeast speciﬁc maximum growth rate [20].
k Extrapolated from Fig. 2D insert.
1 Not available.
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500 N. Lorenzen et al. / FEBS Letters 588 (2014) 497–502of residues 3–5 which is part of the ﬁrst helix (residues 3–37). In
Del2–11, interactions with both DOPG and DMPG are almost com-
pletely eliminated, since deleting residues 3–11 of the helix re-
moves three positively charged residues, weakening electrostaticmonomer-lipid attractions and eliminating dye leakage potency.
The linear correlation in Fig. 2C (insert) predicts a 50% dye leakage
concentration for Del2–11 to be considerably higher than the other
3 aSN constructs. Since we demonstrate that there is a high degree
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cles, it is not surprising that it leads to membrane permeabilization
since general protein adsorption to anionic vesicles can induce ves-
icle leakage [38]. Moreover, previous studies suggest that the aSN
monomers can lead to membrane permeability by bilayer defor-
mation [39,40].
4.3. The N-terminal is essential for oligomer–membrane interaction
Our A4F oligomer-DOPG vesicle binding assay establishes that
wt, Del2 and Del2–5 oligomers interact strongly with vesicles, just
as the monomers of aSN. The observation that aSN oligomers
binds to DOPG vesicles is in agreement with dynamic light scatter-
ing (DLS) data where we have observed an increase in the RH from
109 nm of pure DOPG vesicles to 140 nm when oligomers are pres-
ent (Lorenzen, Nielsen & Otzen unpublished). The DLS experiment
is carried out at a mole ratio of 1:60 (protein:lipid) comparable
with the A4F experiment, and indirectly conﬁrm the validity of
the A4F experiments. Together with the dye leakage assay, we ob-
serve a clear trend for both monomers and oligomers, where wt,
Del2 and Del2–5 showed a high degree of binding and membrane
permeabilization whereas Del2–11 oligomers only induced little
membrane permeabilizing. Although trends in the dye leakage
experiment for the oligomers and monomers were similar, they
were not identical:
Monomers: Del2 > wt > > Del2–5 > > Del2–11
Oligomers: wt > Del2  Del2–5 > > Del2–11
We expected oligomers to permeabilize vesicles much more
strongly than monomers because a large number of N-terminals
in close proximity in the oligomer structure would stress and per-
turb vesicles. In contrast, for monomers the N-terminals would be
widely distributed in the membrane due to electrostatic repulsion
and diffusion, leading to less disorder in the membrane. The fact
that Del2–11 distorts the membrane interaction of both monomers
and oligomers clearly indicates that the N-terminal is important,
given that the different constructs have the same overall size and
hydrophobicity according to DLS and ANS. However, the discrep-
ancy in the ranking of the dye leakage assays indicates that the
interaction of oligomers is not driven solely by the N-termini.
We speculate that the formation of a hydrophobic core and/or
solvent exposed hydrophobic patches in the oligomer structure,
as indicated by ANS binding (Fig. 1C), is important foroligomer–membrane interaction. The importance of hydrophobic
interactions in the membrane binding of aSN oligomers has previ-
ously been demonstrated by Rooijen et al. [41] where an increase
in accessibility of the hydrocarbon core of the lipid bilayer in-
creases bilayer disruption by aSN oligomers. We propose that
the hydrophobic patches together with N-termini in close proxim-
ity in the oligomers could explain the extraordinary toxicity of
oligomers relative to monomers. However, the differences between
the dye leakage ranking of monomers and oligomers could also be
the consequence of structural changes amongst wt, Del2, Del2–5
and Del2–11 oligomers in the positioning of the N-termini or the
arrangement of hydrophobic regions.
Vamvaca et al. [20] showed that N-terminal deletions in aSN
dramatically reduced toxicity towards yeast. While the yeast max-
imum speciﬁc growth rates of Del2, Del2–5 and Del2–11 do not
correlate with the membrane interaction, folding and permeabili-
zation of the monomer form, we note that wt aSN, which in the
oligomeric form shows the highest degree of vesicle disruption,
also shows the greatest toxicity towards yeast.
Building on the observation that the N-terminus is important
for oligomer–membrane interaction [12] we have identiﬁed the
ﬁrst 11 N-terminal residues to be critical for the interaction of both
the monomer and oligomer forms. We suggest that the increased
ability of aSN oligomers to permeabilize membranes compared
to monomers stems from a combination of juxtaposed N-terminal
binding domains and contiguous regions of hydrophobic surface
area resulting from oligomerization.
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